Research DepartmentsPeoplePublicationsPostdoc & Student Positions  
 
 Deeley Research Centre 
Cecile Le Page
Peer-Reviewed Papers
Peer-Reviewed Papers

    2009

  1. Le Page C, Puiffe ML, Meunier L, Zietarska M, de Ladurantaye M, Tonin PN, Provencher D, Mes-Masson AM. BMP-2 signaling in ovarian cancer and its association with poor prognosis. J Ovarian Res. 2009 Apr 14;2:4. (2009).
     [View Abstract - PubMed 19366455]

  2. Peant B, Diallo JS, Dufour F, Le Page C, Delvoye N, Saad F, Mes-Masson AM. Over-expression of IkappaB-kinase-epsilon (IKKepsilon/IKKi) induces secretion of inflammatory cytokines in prostate cancer cell lines. Prostate. 69(7):706-18. (2009).
     [View Abstract - PubMed 19170126]

  3. 2008

  4. Le Page C, Ouellet V, Quinn MC, Tonin PN, Provencher DM, Mes-Masson AM. BTF4/BTNA3.2 and GCS as candidate mRNA prognostic markers in epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev. 17(4):913-20. (2008).
     [View Abstract - PubMed 18398031]

  5. 2007

  6. Ouellet V, Le Page C, Madore J, Guyot MC, Barres V, Lussier C, Tonin PN, Provencher DM, Mes-Masson AM. An apoptotic molecular network identified by microarray: on the TRAIL to new insights in epithelial ovarian cancer. Cancer. 110(2):297-308. (2007).
     [View Abstract - PubMed 17569106]

  7. Puiffe ML, Le Page C, Filali-Mouhim A, Zietarska M, Ouellet V, Tonin PN, Chevrette M, Provencher DM, Mes-Masson AM. Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer. Neoplasia. 9(10):820-9. (2007).
     [View Abstract - PubMed 17971902]

  8. 2006

  9. Le Page C, Koumakpayi IH, Alam-Fahmy M, Mes-Masson AM, Saad F. Expression and localisation of Akt-1, Akt-2 and Akt-3 correlate with clinical outcome of prostate cancer patients. Br J Cancer. 94(12):1906-12. Epub 2006 May 23. (2006).
     [View Abstract - PubMed 16721361]

  10. Le Page C, Ouellet V, Madore J, Hudson TJ, Tonin PN, Provencher DM, Mes-Masson AM. From gene profiling to diagnostic markers: IL-18 and FGF-2 complement CA125 as serum-based markers in epithelial ovarian cancer. Int J Cancer. 118(7):1750-8. (2006).
     [View Abstract - PubMed 16217764]

  11. Le Page C, Ouellet V, Madore J, Ren F, Hudson TJ, Tonin PN, Provencher DM, Mes-Masson AM. Gene expression profiling of primary cultures of ovarian epithelial cells identifies novel molecular classifiers of ovarian cancer. Br J Cancer. 94(3):436-45. (2006).
     [View Abstract - PubMed 16421595]

  12. Ouellet V, Le Page C, Guyot MC, Lussier C, Tonin PN, Provencher DM, Mes-Masson AM. SET complex in serous epithelial ovarian cancer. Int J Cancer. 119(9):2119-26. (2006).
     [View Abstract - PubMed 16823850]

  13. 2005

  14. Le Page C, Koumakpayi IH, Lessard L, Mes-Masson AM, Saad F. EGFR and Her-2 regulate the constitutive activation of NF-kappaB in PC-3 prostate cancer cells. Prostate. 65(2):130-40. (2005).
     [View Abstract - PubMed 15880609]

  15. Le Page C, Koumakpayi IH, Lessard L, Saad F, Mes-Masson AM. Independent role of phosphoinositol-3-kinase (PI3K) and casein kinase II (CK-2) in EGFR and Her-2-mediated constitutive NF-kappaB activation in prostate cancer cells. Prostate. 65(4):306-15. (2005).
     [View Abstract - PubMed 16015604]

  16. 2004

  17. Le Page C, Provencher D, Maugard CM, Ouellet V, Mes-Masson AM. Signature of a silent killer: expression profiling in epithelial ovarian cancer. Expert Rev Mol Diagn. 4(2):157-67. (2004).
     [View Abstract - PubMed 14995903]

  18. 2003

  19. Le Page C, Wietzerbin J. Modulation of the activation of extracellular signal-regulated kinase (ERK) and the production of inflammatory mediators by ADP-ribosylation inhibitors. Biol Chem. 384(10-11):1509-13. (2003).
     [View Abstract - PubMed 14669994]

  20. 2001

  21. Le Page C, Popescu O, Genin P, Lian J, Paquin A, Galipeau J, Hiscott J. Disruption of NF-kappa B signaling and chemokine gene activation by retroviral mediated expression of IKK gamma/NEMO mutants. Virology. 286(2):422-33. (2001).
     [View Abstract - PubMed 11485410]

  22. 2000

  23. Le Page C, Genin P, Baines MG, Hiscott J. Interferon activation and innate immunity. Rev Immunogenet. 2(3):374-86. (2000).
     [View Abstract - PubMed 11256746]


Top of Page Prev (4 of 27) Next

URL: http://www.bccrc.ca/drc/pubs_clepage.html
The BC Cancer Agency Research Centre is the research arm of the BC Cancer Agency (BCCA),
and is supported by the BC Cancer Foundation.
This page was last modified at 11:21am on June 11, 2009
© 1999-2008. BC Cancer Agency. All rights reserved.
About this website...

 
Navigation Menu

View Site Map

Contact Us

BC Cancer Agency Research Centre
675 West 10th Avenue
Vancouver, BC
V5Z 1L3  Canada
1-604-675-8000


We subscribe to the HONcode principles of the Health On the Net Foundation